1. Home
  2. NKTR vs QRTEA Comparison

NKTR vs QRTEA Comparison

Compare NKTR & QRTEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • QRTEA
  • Stock Information
  • Founded
  • NKTR 1990
  • QRTEA 1991
  • Country
  • NKTR United States
  • QRTEA United States
  • Employees
  • NKTR N/A
  • QRTEA N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • QRTEA Catalog/Specialty Distribution
  • Sector
  • NKTR Health Care
  • QRTEA Consumer Discretionary
  • Exchange
  • NKTR Nasdaq
  • QRTEA Nasdaq
  • Market Cap
  • NKTR 238.7M
  • QRTEA 239.9M
  • IPO Year
  • NKTR 1994
  • QRTEA N/A
  • Fundamental
  • Price
  • NKTR $1.30
  • QRTEA $0.62
  • Analyst Decision
  • NKTR Buy
  • QRTEA
  • Analyst Count
  • NKTR 4
  • QRTEA 0
  • Target Price
  • NKTR $2.50
  • QRTEA N/A
  • AVG Volume (30 Days)
  • NKTR 1.0M
  • QRTEA 2.8M
  • Earning Date
  • NKTR 11-05-2024
  • QRTEA 11-01-2024
  • Dividend Yield
  • NKTR N/A
  • QRTEA N/A
  • EPS Growth
  • NKTR N/A
  • QRTEA N/A
  • EPS
  • NKTR N/A
  • QRTEA N/A
  • Revenue
  • NKTR $93,157,000.00
  • QRTEA $10,371,000,000.00
  • Revenue This Year
  • NKTR N/A
  • QRTEA N/A
  • Revenue Next Year
  • NKTR N/A
  • QRTEA N/A
  • P/E Ratio
  • NKTR N/A
  • QRTEA N/A
  • Revenue Growth
  • NKTR 6.17
  • QRTEA N/A
  • 52 Week Low
  • NKTR $0.41
  • QRTEA $0.40
  • 52 Week High
  • NKTR $1.93
  • QRTEA $1.80
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 53.41
  • QRTEA 54.49
  • Support Level
  • NKTR $1.26
  • QRTEA $0.58
  • Resistance Level
  • NKTR $1.42
  • QRTEA $0.70
  • Average True Range (ATR)
  • NKTR 0.09
  • QRTEA 0.04
  • MACD
  • NKTR 0.01
  • QRTEA 0.01
  • Stochastic Oscillator
  • NKTR 59.71
  • QRTEA 48.33

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About QRTEA Qurate Retail Inc. Series A

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

Share on Social Networks: